Veradigm PE Ratio 2011-2022 | MDRX
Current and historical p/e ratio for Veradigm (MDRX) from 2011 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veradigm PE ratio as of November 14, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veradigm PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-13 | 4.90 | 0.00 | |
| 2022-12-31 | 17.64 | $-0.25 | 0.00 |
| 2022-09-30 | 15.23 | $0.43 | 35.42 |
| 2022-06-30 | 14.83 | $0.43 | 34.49 |
| 2022-03-31 | 22.52 | $1.12 | 20.11 |
| 2021-12-31 | 18.45 | $1.01 | 18.27 |
| 2021-09-30 | 13.37 | $5.15 | 2.60 |
| 2021-06-30 | 18.51 | $5.03 | 3.68 |
| 2021-03-31 | 15.02 | $4.83 | 3.11 |
| 2020-12-31 | 14.44 | $4.64 | 3.11 |
| 2020-09-30 | 8.14 | $-0.30 | 0.00 |
| 2020-06-30 | 6.77 | $-0.33 | 0.00 |
| 2020-03-31 | 7.04 | $-1.18 | 0.00 |
| 2019-12-31 | 9.82 | $-1.09 | 0.00 |
| 2019-09-30 | 10.98 | $1.17 | 9.38 |
| 2019-06-30 | 11.63 | $1.00 | 11.63 |
| 2019-03-31 | 9.54 | $2.26 | 4.22 |
| 2018-12-31 | 9.64 | $2.08 | 4.63 |
| 2018-09-30 | 14.25 | $-0.03 | 0.00 |
| 2018-06-30 | 12.00 | $0.01 | 1200.00 |
| 2018-03-31 | 12.35 | $-1.20 | 0.00 |
| 2017-12-31 | 14.55 | $-1.09 | 0.00 |
| 2017-09-30 | 14.23 | $-1.16 | 0.00 |
| 2017-06-30 | 12.76 | $-1.06 | 0.00 |
| 2017-03-31 | 12.68 | $-0.26 | 0.00 |
| 2016-12-31 | 10.21 | $-0.14 | 0.00 |
| 2016-09-30 | 13.17 | $-0.01 | 0.00 |
| 2016-06-30 | 12.70 | $0.02 | 635.00 |
| 2016-03-31 | 13.21 | $0.06 | 220.17 |
| 2015-12-31 | 15.38 | $-0.01 | 0.00 |
| 2015-09-30 | 12.40 | $-0.11 | 0.00 |
| 2015-06-30 | 13.68 | $-0.23 | 0.00 |
| 2015-03-31 | 11.96 | $-0.31 | 0.00 |
| 2014-12-31 | 12.77 | $-0.37 | 0.00 |
| 2014-09-30 | 13.42 | $-0.48 | 0.00 |
| 2014-06-30 | 16.05 | $-0.60 | 0.00 |
| 2014-03-31 | 18.03 | $-0.64 | 0.00 |
| 2013-12-31 | 15.46 | $-0.59 | 0.00 |
| 2013-09-30 | 14.87 | $-0.61 | 0.00 |
| 2013-06-30 | 12.94 | $-0.29 | 0.00 |
| 2013-03-31 | 13.59 | $-0.12 | 0.00 |
| 2012-12-31 | 9.42 | $-0.02 | 0.00 |
| 2012-09-30 | 12.42 | $0.26 | 47.77 |
| 2012-06-30 | 10.93 | $0.32 | 34.16 |
| 2012-03-31 | 16.60 | $0.36 | 46.11 |
| 2011-12-31 | 18.94 | $0.39 | 48.56 |
| 2011-09-30 | 18.02 | $0.22 | 81.91 |
| 2011-06-30 | 19.42 | $0.12 | 161.83 |
| 2011-03-31 | 20.99 | $0.14 | 149.93 |
| 2010-12-31 | 19.27 | $0.08 | 240.88 |
| 2010-09-30 | 18.47 | $0.23 | 80.30 |
| 2010-06-30 | 16.10 | $0.22 | 73.18 |
| 2010-05-31 | 18.81 | $0.12 | 156.75 |
| 2010-03-31 | 19.58 | $0.12 | 163.17 |
| 2010-02-28 | 17.89 | $0.09 | 198.78 |
| 2009-12-31 | 20.23 | $0.09 | 224.78 |
| 2009-11-30 | 19.20 | $0.09 | 213.33 |
| 2009-09-30 | 20.27 | $0.09 | 225.22 |
| 2009-08-31 | 14.85 | 0 | 0.00 |
| 2009-05-31 | 12.91 | $0.07 | 184.43 |
| 2009-02-28 | 8.70 | $0.07 | 124.29 |
| 2008-11-30 | 7.70 | $0.11 | 70.00 |
| 2008-09-30 | 6.61 | $0.11 | 60.09 |
| 2008-08-31 | 7.62 | $0.04 | 190.49 |
| 2008-06-30 | 6.59 | $0.04 | 164.86 |
| 2008-05-31 | 6.60 | $0.10 | 66.05 |
| 2008-03-31 | 5.48 | $0.10 | 54.84 |
| 2008-02-29 | 5.67 | $0.17 | 33.35 |
| 2007-12-31 | 10.32 | $0.27 | 38.22 |
| 2007-11-30 | 9.40 | $0.17 | 55.29 |
| 2007-09-30 | 14.36 | $0.25 | 57.45 |
| 2007-06-30 | 13.54 | $0.25 | 54.16 |
| 2007-05-31 | 13.05 | $0.21 | 62.14 |
| 2007-03-31 | 14.25 | $0.26 | 54.79 |
| 2006-12-31 | 14.34 | $0.21 | 68.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.523B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $12.183B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $2.011B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.045B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |